Peptide synthesis
has opened new frontiers in the quest
for bioactive
molecules with limitless biological applications. This study presents
the synthesis of a series of novel isoquinoline dipeptides using advanced
spectroscopic techniques for characterization. These compounds were
designed with the goal of discovering unexplored biological activities
that could contribute to the development of novel pharmaceuticals.
We evaluated the biological activities of novel compounds including
their antimicrobial, antibacterial, and antifungal properties. The
results show promising activity against
Escherichia
coli
and potent antibacterial activity against MTCC
443 and MTCC 1688. Furthermore, these compounds demonstrate strong
antifungal activity, outperforming existing standard drugs. Computational
binding affinity studies of tetrahydroisoquinoline-conjugated dipeptides
against
E. coli
DNA gyrase displayed
significant binding interactions and binding affinity, which are reflected
in antimicrobial activities of compounds. Our integrative significant
molecular findings from both wet and dry laboratories would help pave
a path for the development of antimicrobial therapeutics. The findings
suggest that these isoquinoline-conjugated dipeptides could be excellent
candidates for drug development, with potential applications in the
fight against bacterial and fungal infections. This research represents
an exciting step forward in the field of peptide synthesis and its
potential to discover novel bioactive molecules with significant implications
for human health.